Notis-McConarty Edward’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.47M Sell
30,551
-1,055
-3% -$246K 3.71% 8
2025
Q4
$6.54M Sell
31,606
-635
-2% -$126K 3.03% 11
2025
Q3
$5.98M Sell
32,241
-630
-2% -$108K 2.78% 12
2025
Q2
$5.02M Sell
32,871
-3,905
-11% -$600K 2.45% 16
2025
Q1
$6.1M Sell
36,776
-427
-1% -$66.8K 3.14% 11
2024
Q4
$5.38M Sell
37,203
-1,194
-3% -$185K 2.6% 14
2024
Q3
$6.22M Sell
38,397
-7,685
-17% -$1.22M 2.82% 12
2024
Q2
$6.74M Sell
46,082
-1,320
-3% -$196K 2.65% 11
2024
Q1
$7.5M Sell
47,402
-3,630
-7% -$578K 2.96% 9
2023
Q4
$8M Sell
51,032
-860
-2% -$132K 3.19% 9
2023
Q3
$8.08M Sell
51,892
-4
-0% -$660 3.29% 8
2023
Q2
$8.59M Sell
51,896
-820
-2% -$132K 3.27% 8
2023
Q1
$8.17M Buy
52,716
+75
+0.1% +$12.1K 3.25% 8
2022
Q4
$9.3M Sell
52,641
-9
-0% -$1.55K 3.87% 4
2022
Q3
$8.6M Sell
52,650
-24
-0% -$4.06K 3.85% 3
2022
Q2
$9.35M Sell
52,674
-152
-0.3% -$27.1K 3.9% 3
2022
Q1
$9.36M Buy
52,826
+60
+0.1% +$10.2K 3.34% 7
2021
Q4
$9.03M Buy
52,766
+212
+0.4% +$34.7K 3.01% 9
2021
Q3
$8.49M Buy
52,554
+1,356
+3% +$231K 3.11% 8
2021
Q2
$8.43M Sell
51,198
-327
-0.6% -$54.1K 3.12% 7
2021
Q1
$8.47M Buy
51,525
+1,315
+3% +$213K 3.3% 7
2020
Q4
$7.9M Sell
50,210
-278
-0.6% -$41K 3.22% 7
2020
Q3
$7.52M Sell
50,488
-345
-0.7% -$51K 3.3% 6
2020
Q2
$7.15M Sell
50,833
-162
-0.3% -$23.6K 3.33% 6
2020
Q1
$6.69M Sell
50,995
-633
-1% -$89.8K 3.7% 6
2019
Q4
$7.53M Sell
51,628
-1,605
-3% -$218K 3.35% 6
2019
Q3
$6.89M Sell
53,233
-820
-2% -$108K 3.23% 6
2019
Q2
$7.53M Sell
54,053
-1,540
-3% -$213K 3.55% 4
2019
Q1
$7.77M Sell
55,593
-750
-1% -$100K 3.75% 3
2018
Q4
$7.27M Buy
56,343
+2,975
+6% +$415K 4.01% 2
2018
Q3
$7.38M Buy
53,368
+775
+1% +$103K 3.94% 3
2018
Q2
$6.38M Sell
52,593
-790
-1% -$98.6K 3.78% 4
2018
Q1
$6.84M Sell
53,383
-2,159
-4% -$292K 4.1% 3
2017
Q4
$7.76M Buy
55,542
+1,780
+3% +$248K 4.46% 1
2017
Q3
$6.99M Sell
53,762
-1,275
-2% -$169K 4.38% 1
2017
Q2
$7.28M Sell
55,037
-410
-0.7% -$52.3K 4.71% 1
2017
Q1
$6.91M Sell
55,447
-1,000
-2% -$119K 4.53% 1
2016
Q4
$6.5M Sell
56,447
-150
-0.3% -$17.3K 4.48% 1
2016
Q3
$6.68M Sell
56,597
-1,180
-2% -$143K 4.57% 1
2016
Q2
$7.01M Sell
57,777
-305
-0.5% -$34.7K 4.91% 1
2016
Q1
$6.29M Sell
58,082
-675
-1% -$69.9K 4.46% 1
2015
Q4
$6.04M Sell
58,757
-180
-0.3% -$18.1K 4.33% 1
2015
Q3
$5.5M Buy
58,937
+25
+0% +$2.42K 4.11% 1
2015
Q2
$5.74M Buy
58,912
+1,724
+3% +$173K 3.88% 1
2015
Q1
$5.75M Sell
57,188
-295
-0.5% -$30K 3.98% 1
2014
Q4
$6.01M Buy
57,483
+252
+0.4% +$26.6K 4.11% 1
2014
Q3
$6.1M Sell
57,231
-8,885
-13% -$922K 4.3% 1
2014
Q2
$6.92M Sell
66,116
-1,615
-2% -$163K 4.58% 1
2014
Q1
$6.65M Sell
67,731
-1,070
-2% -$99.2K 4.64% 1
2013
Q4
$6.3M Buy
+68,801
New +$6.34M 4.42% 2

Other funds holding JNJ

Notis-McConarty Edward's JNJ Position: Q1 2026 in Review

Notis-McConarty Edward reduced its Johnson & Johnson (JNJ) stake by 3.3% in Q1 2026, selling an estimated $246K and leaving 30,551 shares worth $7.47M. The position accounts for 3.71% of the portfolio, ranked #8.

Notis-McConarty Edward first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. The position peaked at $9.36M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Notis-McConarty Edward held 30,551 shares of Johnson & Johnson worth $7.47M as of Q1 2026.
  • Notis-McConarty Edward sold 1,055 Johnson & Johnson shares in Q1 2026, an estimated $246K.
  • Johnson & Johnson made up 3.71% of Notis-McConarty Edward's portfolio in Q1 2026, its #8 holding.
  • Notis-McConarty Edward first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • Notis-McConarty Edward's Johnson & Johnson position peaked at $9.36M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Notis-McConarty Edward's 13F filing for Q1 2026, filed 8 May 2026.